THE NERVE HEALER

ARA-290

Grade BGood

Nerve repair and pain relief without affecting blood cells

Also known as: Cibinetide, PH-BSP

Metabolic Modulator
Accelerated Healing
Pain Management

Overview

ARA-290 is derived from erythropoietin (EPO) but engineered to provide tissue repair benefits without increasing red blood cell production. It targets a special repair receptor in your nerves and tissues, reducing inflammation and promoting healing. It's particularly promising for diabetic neuropathy and other nerve damage conditions.

Key Benefits & Mechanisms

Repair Receptor

Activates innate repair receptors without stimulating blood cell production

Nerve Protection

Protects neurons from oxidative stress and promotes regeneration

Anti-Inflammatory

Reduces inflammation through NF-κB inhibition

Blood Sugar

Helps regulate blood glucose and metabolic function

Dosing Guide

Dosage

4 mg daily

Schedule

daily

Cycle

4 weeks on, 4 weeks off

Pro Tip

Subcutaneous injection; morning dosing recommended

Safety Profile

B

Good Safety

Good

Well-tolerated in clinical trials with minimal side effects.

Still in clinical development. Best results seen in diabetic and neuropathic conditions.

Possible Side Effects

Mild injection site reaction
Transient headache
Slight fatigue

What to Expect

Week 1

Initial anti-inflammatory effects begin

Week 2

Reduced pain and improved sensation

Week 3-4

Nerve fiber density improvement, sustained pain relief

Pain relief often noticeable within 2 weeks; nerve regeneration takes longer.

Who Is This For

People with diabetic neuropathy
Those suffering from small fiber neuropathy
Chronic pain patients
Type 2 diabetics needing nerve protection
Post-surgical healing support

Research References

Related Peptides

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App